ask="N/A"
ask_size="N/A"
average_daily_volume="500755"
bid="71.11"
bid_size="1000"
book_value="11.38"
change="+0.24"
change_from_200_day_moving_average="3.84"
change_from_50_day_moving_average="1.78"
change_from_52_week_high="-12.87"
change_From_52_week_low="27.38"
change_in_percent="+0.33%"
close="73.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="74.50"
high_52_weeks="86.77"
last_trade_date="2/10/2017"
last_trade_price="73.90"
last_trade_size="12923"
last_trade_time="4:00pm"
low="72.26"
low_52_weeks="46.52"
market_capitalization="3.02B"
moving_average_200_day="70.06"
moving_average_50_day="72.12"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="73.87"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+5.48%"
percent_change_from_50_day_moving_average="+2.46%"
percent_change_from_52_week_high="-14.83%"
percent_change_from_52_week_low="+58.86%"
previous_close="73.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.47"
price_per_sales="23513.08"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="12.30"
stock_exchange="NMS"
symbol="RARE"
volume="371858"
weeks_range_52="46.52 - 86.77"
